myasthenia gravismultifocal motor neuropathyChronic inflammatory demyelinating polyradiculoneuropathycommon variable immunodeficiencyCIDPsecondary immunodeficiencyhaematological disordersIVIgtertiary hospital
…label. Evidence-supported off-label use represented 20.3%, with myasthenia gravis being the most common indication (13/153, 8.5%). While unsuppor…